NULISA employs a sequential immunocomplex capture and release technique to improve the sensitivity of traditional proximity ...

The USA's proteomics market grows steadily, driven by NIH funding in personalized medicine, while Canada is expected to grow ...

Iowa State University scientists have made a significant breakthrough in scientists' ability to identify specific proteins ...

Multi-omics integration combines genomics, proteomics, and more, offering a comprehensive view of complex biological systems ...

Illumina, Inc., a leader in DNA sequencing and array technologies, has launched a pilot proteomics program analyzing 50,000 ...

Platinum Pro is Quantum-Si’s newest Next-Generation Protein Sequencer™ built from the foundation of innovation established by ...

Illumina (ILMN) announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with deCODE Genetics, Standard ...

UK Biobank has today announced the launch of the world's most comprehensive study of the proteins circulating in our bodies, which will transform the study of diseases and their treatments.

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to assess the levels of 5,400 different ...

A consortium of 14 pharmaceutical companies will now use those samples and start the largest proteomics study to date.

Quantum-Si's NGPS technology disrupts protein analysis market, but recent equity raise and execution risks lead to Sell ...